Skip to content

Perspectives on Enquiry & Evidence

The world's leading supplier of statistical insight to decision-makers in the lifesciences brings you debate and discussion of the newest trends in statistics and quantitative strategy.
November 30, 2021

The FDA “Real-Time Oncology Review” Process

The FDA “Real-Time Oncology Review (RTOR)”[1] is an “FDA project started in 2018 to facilitate earlier submission of..
Read article
March 30, 2021

The Integration Dilemma

As of today, our Industry has not defined any approach, nor does an official regulatory agency..
Read article